HCW Biologics's market cap is currently $8.22M. The company's EPS TTM is $-6.79; its P/E ratio is ―; HCW Biologics is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is $1.58. See an overview of income statement, balance sheet, and cash flow financials.
